ノースカロライナにおけるCOPDの臨床試験
ノースカロライナ内の拠点で、COPDに関する22件の研究が参加者を募集しています。
ノースカロライナ内の都市
公式研究テキスト（英語）
Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD), Characterized by an Eosinophilic Phenotype
- East Carolina University- Site Number : 8400102, Greenville
- Piedmont Healthcare - Family Medicine- Site Number : 8400022, Statesville
- All-Trials Clinical Research- Site Number : 8400008, Winston-Salem
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/10/01更新 · NCT07190222To Evaluate the Effect of EXPD-101/FXS7553 Compared With Placebo in Patients With COPD Over 52 Weeks of Treatment
- Carolina Research Center, Inc., Shelby
被験者募集中第2相
40歳〜85歳 · 全性別 · 2026/09/30更新 · NCT07684820A Study to Investigate Airway Inflammation With Dupilumab Subcutaneously in Participants Aged ≥40 to ≤85 Years With Chronic Obstructive Pulmonary Disease.
- American Health Research - Charlotte- Site Number : 8400013, Charlotte
- Atrium Health Wake Forest Baptist Pulmonary, Sleep And Allergy- Site Number : 8400004, Winston-Salem
被験者募集中第4相
40歳〜85歳 · 全性別 · 2026/09/22更新 · NCT07053423Efficacy, Safety, and Tolerability Study of Lunsekimig Compared With Placebo in Adult Participants With Inadequately Controlled Chronic Obstructive Pulmonary Disease (COPD) Characterized by an Eosinophilic Phenotype
- Duke Asthma, Allergy and Airway Center- Site Number : 8400047, Durham
- Advanced Respiratory and Sleep Medicine - Hickory- Site Number : 8400013, Hickory
- Science 37, Llc- Site Number : 8400154, Morrisville
- 他1件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/22更新 · NCT07190209A Study of WIN378 in Participants With Moderate to Severe COPD (Sirius)
- WB Contracted Clinical Research Site, Charlotte
被験者募集中第2相
40歳〜80歳 · 全性別 · 2026/09/15更新 · NCT07646587Nebulizer Versus Handheld Maintenance Therapy for Patients With COPD
- Southeastern Research Center, Winston-Salem
被験者募集中第4相
60歳以上 · 全性別 · 2026/09/14更新 · NCT07816835A Study to Investigate the Effect of AZD6793 in Participants With Moderate to Very Severe Chronic Obstructive Pulmonary Disease
- Research Site, New Bern
被験者募集中第2相
40歳以上 · 全性別 · 2026/09/09更新 · NCT07082738A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00007)
- Research Site, Charlotte
- Research Site, Concord
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06878261A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
- Research Site, High Point
- Research Site, Kings Mountain
- Research Site, New Bern
- 他1件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/09/03更新 · NCT06883305A Study to Test the Safety and Effects of Inhaled GDC-6988 in Participants With Muco-obstructive Disease
- University of North Carolina Clinical Research Center, Chapel Hill
被験者募集中第1相
18歳以上 · 全性別 · 2026/09/02更新 · NCT06603246The Study of Chronic Obstructive Pulmonary Disease (COPD) Participants Treated With Dupilumab (STRIDE) Registry
- Duke, Durham
被験者募集中観察研究
40歳以上 · 全性別 · 2026/09/01更新 · NCT07612878A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Salem Chest Specialists, Winston-Salem
- Southeastern Research Center, Winston-Salem
被験者募集中第2/3相
35歳〜80歳 · 全性別 · 2026/08/31更新 · NCT07363694Inhaled Treprostinil (Tyvaso Nebulizer) For COPD Patients With Hypoxemia
- Duke Asthma Allergy and Airway Center, Durham
被験者募集中第2相
40歳以上 · 全性別 · 2026/08/27更新 · NCT07037836Photon-counting CT in Chest Imaging
- Duke University Hospital, Durham
被験者募集中
全年齢 · 全性別 · 2026/08/26更新 · NCT07031336A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
- Research Site, Greensboro
- Research Site, Greenville
- Research Site, Huntersville
- 他3件
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/08/26更新 · NCT06283966STRIVE Post-Market Registry Study
- Duke University Medical Center, Durham
被験者募集中観察研究
18歳以上 · 全性別 · 2026/08/03更新 · NCT04302272eValuating the Efficacy and Safety of InitiatinG depemokImab earLy therApy iN Chronic Obstructive Pulmonary Disorder (COPD) With Type 2 Inflammation
- GSK Investigational Site, Winston-Salem
被験者募集中第3相
40歳〜75歳 · 全性別 · 2026/07/28更新 · NCT07177339SPIROMICS Study of Early COPD Progression (SOURCE)
- Wake Forest, Winston-Salem
被験者募集中観察研究健康なボランティア歓迎
30歳〜55歳 · 全性別 · 2026/06/03更新 · NCT05033990Evaluating the Safety and Efficacy of dNerva Lung Denervation System in Patients With COPD
- Wake Forest School of Medicine, Salem
被験者募集中
40歳〜80歳 · 全性別 · 2026/04/28更新 · NCT07051707Depemokimab as an Extended treatmeNt Duration Biologic in Adults With Chronic Obstructive Pulmonary Disease (COPD) and Type 2 Inflammation (ENDURA-2)
- GSK Investigational Site, Shelby
被験者募集中第3相
40歳〜80歳 · 全性別 · 2026/04/09更新 · NCT06961214Pulmonary Hypertension SOLAR
- Duke University Medical Center, Durham
被験者募集中第2相
18歳以上 · 全性別 · 2026/02/24更新 · NCT04778046Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
- Wakemed, Raleigh
被験者募集中観察研究
50歳以上 · 全性別 · 2025/08/05更新 · NCT06122077ClinicalTrials.govより、2026/10/02時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。